Publications

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

Download PDF
Resource: Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

.

Related Articles

Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution

Link
Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer

Link